Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$6.7 million for Q4 2025.

• On a quarterly basis, Cash from Financing Activities rose 87.5% year-over-year to -$6.7 million in Q4 2025; TTM through Dec 2025 was -$129.5 million, a 45.84% increase from a year earlier, with the FY2025 full-year figure at -$182.1 million, up 24.45% from the prior year.
• Cash from Financing Activities climbed to -$6.7 million in Q4 2025 per PBH's latest filing, from -$74.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $63.6 million in Q2 2021 and bottomed at -$83.7 million in Q1 2021.
• The 5-year median for Cash from Financing Activities is -$53.7 million (2023), against an average of -$40.9 million.
• Biggest YoY gain for Cash from Financing Activities was 167.11% in 2021; the steepest drop was 647.88% in 2021.
• Year by year, Cash from Financing Activities stood at -$67.6 million in 2021, then soared by 85.18% to -$10.0 million in 2022, then slumped by 547.07% to -$64.8 million in 2023, then climbed by 16.93% to -$53.9 million in 2024, then jumped by 87.5% to -$6.7 million in 2025.
• Per Business Quant, the three latest PBH Cash from Financing Activities figures stand at -$6.7 million (Q4 2025), -$74.9 million (Q3 2025), and -$36.3 million (Q2 2025).